The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis
暂无分享,去创建一个
Malcolm W R Reed | Nicola J Brown | M. Reed | N. Brown | R. Ackroyd | Clive J Kelty | Roger Ackroyd | C. Kelty
[1] C. Rimington. Porphyrin and haem biosynthesis and its control. , 2009, Acta medica Scandinavica. Supplementum.
[2] M. Goldman,et al. ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy , 2003, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.
[3] Peter D Siersema,et al. Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus. , 2002, Journal of photochemistry and photobiology. B, Biology.
[4] H Stepp,et al. Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. , 2001, The Journal of urology.
[5] C. Whitehurst,et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. , 2001, Archives of dermatology.
[6] T. Stephenson,et al. Photodynamic therapy for dysplastic Barrett's oesophagus: long‐term follow‐up , 2001 .
[7] P. Devitt,et al. Laparoscopic Nissen versus anterior fundoplication in patients with oesophageal dysmotility: a randomized controlled trial , 2001 .
[8] Thomas J. Dougherty,et al. Basic principles of photodynamic therapy , 2001 .
[9] D. Ladner,et al. Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid , 2001, British Journal of Cancer.
[10] A. Curnow,et al. Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. , 2000, Journal of photochemistry and photobiology. B, Biology.
[11] T. Stephenson,et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial , 2000, Gut.
[12] C. Whitehurst,et al. Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy , 2000, The British journal of dermatology.
[13] R. Anderson,et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. , 2000, The Journal of investigative dermatology.
[14] S. Tajima,et al. Topical δ‐Aminolevulinic Acid‐Based Photodynamic Therapy for Japanese Actinic Keratoses , 2000 .
[15] J Moan,et al. Phototransformations of 5-Aminolevulinic Acid–induced Protoporphyrin IX in vitro: A Spectroscopic Study¶ , 2000, Photochemistry and photobiology.
[16] H Stepp,et al. Assessment of 5-aminolevulinic acid-induced porphyrin fluorescence in patients with peritoneal endometriosis. , 2000, American journal of obstetrics and gynecology.
[17] J. Moan,et al. Photodynamic Therapy of Superficial Basal Cell Carcinoma with 5-Aminolevulinic Acid with Dimethylsulfoxide and Ethylendiaminetetraacetic Acid: A Comparison of Two Light Sources , 2000, Photochemistry and photobiology.
[18] H Stepp,et al. Photodetection of cervical intraepithelial neoplasia using 5‐aminolevulinic acid–induced porphyrin fluorescence , 2000, Cancer.
[19] U. Pichlmeier,et al. No Generalized Skin Phototoxicity after Intravesical Application of 5-Aminolevulinic Acid for Fluorescence Diagnosis ofSuperficial Bladder Cancer , 2000, Urologia Internationalis.
[20] R Jakobs,et al. Photodynamic therapy with 5-aminolevulinic acid is not effective in bile duct cancer. , 2000, Gastrointestinal endoscopy.
[21] Christian Gluud,et al. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial , 2000, The Lancet.
[22] H Stepp,et al. Photodynamic therapy of vulvar intraepithelial neoplasia using 5‐aminolevulinic acid , 2000, International journal of cancer.
[23] B. Jarvis,et al. Topical Aminolevulinic Acid HCl Photodynamic Therapy , 2000, American journal of clinical dermatology.
[24] Z. Halpern,et al. [Photodynamic therapy for dysphagia due to esophageal carcinoma]. , 1999, Harefuah.
[25] H. Barr,et al. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. , 1999, Journal of photochemistry and photobiology. B, Biology.
[26] G. Stables,et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. , 1999, Acta dermato-venereologica.
[27] J. McEwan,et al. Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty , 1999, The British journal of surgery.
[28] T. Stephenson,et al. 5‐Aminolevulinic Acid Photosensitization of Dysplastic Barrett's Esophagus: A Pharmacokinetic Study , 1999, Photochemistry and photobiology.
[29] Herbert Stepp,et al. Transurethral Resection and Surveillance of Bladder Cancer Supported by 5-Aminolevulinic Acid-Induced Fluorescence Endoscopy , 1999, European Urology.
[30] I. Stender,et al. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5‐aminolaevulinic acid: a pilot study , 1999, Clinical and experimental dermatology.
[31] A. Berner,et al. Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. , 1999, Acta dermato-venereologica.
[32] K Svanberg,et al. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. , 1999, Acta ophthalmologica Scandinavica.
[33] M Korell,et al. Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5‐aminolevulinic acid , 1999, International journal of cancer.
[34] Robinson,et al. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy , 1999, The British journal of dermatology.
[35] K. Schomacker,et al. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5‐aminolaevulinic acid , 1999, BJU international.
[36] Alison Curnow,et al. Light Dose Fractionation to Enhance Photodynamic Therapy Using 5‐Aminolevulinic Acid in the Normal Rat Colon , 1999, Photochemistry and photobiology.
[37] J. Mühling,et al. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid. , 1998, International journal of oral and maxillofacial surgery.
[38] J. Moan,et al. Kinetics of Photobleaching of Protoporphyrin IX in the Skin of Nude Mice Exposed to Different Fluence Rates of Red Light , 1998, Photochemistry and photobiology.
[39] A. J. MacRobert,et al. Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. , 1998, British Journal of Cancer.
[40] H. Soyer,et al. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. , 1998, Archives of dermatology.
[41] L. Gossner,et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid , 1998 .
[42] H Stepp,et al. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors. , 1998, The Journal of urology.
[43] D. Kessel,et al. Mitochondrial photodamage and PDT-induced apoptosis. , 1998, Journal of photochemistry and photobiology. B, Biology.
[44] Joris Kloek,et al. Derivatives of 5‐Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into Protoporphyrin , 1998, Photochemistry and photobiology.
[45] H Kerl,et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. , 1997, Journal of photochemistry and photobiology. B, Biology.
[46] T. Ruzicka,et al. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses , 1997, Photodermatology, photoimmunology & photomedicine.
[47] H Stepp,et al. Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. , 1997, Journal of photochemistry and photobiology. B, Biology.
[48] D. Ash,et al. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy , 1997, The British journal of dermatology.
[49] D. Kessel,et al. Side effects and photosensitization of human tissues after aminolevulinic acid. , 1997, The Journal of surgical research.
[50] H Stepp,et al. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.
[51] M. Korbelik,et al. Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.
[52] P. Speight,et al. Photodynamic therapy using 5‐aminolevulinic acid for premalignant and malignant lesions of the oral cavity , 1996, Cancer.
[53] H. Barr,et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.
[54] Q. Peng,et al. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. , 1996, British Journal of Cancer.
[55] G Hüttmann,et al. Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours. , 1996, Journal of photochemistry and photobiology. B, Biology.
[56] P Baas,et al. Photodynamic therapy: a promising new modality for the treatment of cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.
[57] J Moan,et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. , 1996, Journal of Photochemistry and Photobiology. B: Biology.
[58] R Baumgartner,et al. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. , 1996, British journal of urology.
[59] N. J. Brown,et al. The effect of aminolaevulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo. , 1995, British Journal of Cancer.
[60] P. Calzavara-Pinton,et al. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.
[61] A Gorchein,et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. , 1995, Gut.
[62] R Baumgartner,et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. , 1994, Urology.
[63] N. Brown,et al. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder. , 1994, The Journal of urology.
[64] R. Knüchel,et al. [Photodynamic diagnosis of urothelial neoplasms after intravesicular instillation of 5-aminolevulinic acid]. , 1994, Der Urologe (Ausg. A).
[65] Sharon Thomsen,et al. PHOTODYNAMIC THERAPY WITH PHOTOFRIN II INDUCES PROGRAMMED CELL DEATH IN CARCINOMA CELL LINES , 1994, Photochemistry and photobiology.
[66] D. V. Ash,et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.
[67] D. Vernon,et al. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. , 1993, Journal of photochemistry and photobiology. B, Biology.
[68] P. Speight,et al. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid , 1993, The Lancet.
[69] A. J. MacRobert,et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. , 1993, British Journal of Cancer.
[70] H. Pass,et al. Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.
[71] P B Cerrito,et al. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer Research.
[72] S. G. Bown,et al. Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. , 1992, British Journal of Cancer.
[73] J. Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[74] D. Phillips,et al. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. , 1992, British Journal of Cancer.
[75] A Gorchein,et al. Sustained high plasma 5‐aminolaevulinic acid concentration in a volunteer: no porphyric symptoms , 1992, European journal of clinical investigation.
[76] T. Dougherty,et al. HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.
[77] M L Agarwal,et al. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. , 1991, Cancer research.
[78] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[79] J C Kennedy,et al. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. , 1990, The American journal of pathology.
[80] M T Tseng,et al. The effect of photodynamic therapy on the microcirculation. , 1988, The Journal of surgical research.
[81] Z. Malik,et al. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. , 1987, British Journal of Cancer.
[82] H. Barr,et al. THE CONTRASTING MECHANISMS OF COLONIC COLLAGEN DAMAGE BETWEEN PHOTODYNAMIC THERAPY and THERMAL INJURY , 1987, Photochemistry and photobiology.
[83] J Moan,et al. A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice. , 1987, Cancer letters.
[84] J Moan,et al. PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.
[85] J C Kennedy,et al. NON‐INVASIVE TECHNIQUE FOR OBTAINING FLUORESCENCE EXCITATION AND EMISSION SPECTRA IN VIVO , 1986, Photochemistry and photobiology.
[86] J Moan,et al. Effect of bleaching of porphyrin sensitizers during photodynamic therapy. , 1986, Cancer letters.
[87] T. Mang,et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.
[88] J. Reynoldson,et al. Neuropharmacology of delta-aminolaevulinic acid—I Effect of acute administration in rodents , 1984, Neuropharmacology.
[89] T. Dougherty,et al. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. , 1981, Cancer research.
[90] J. Kennedy,et al. Experimental Porphyric Neuropathy: A Preliminary Report , 1981, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[91] Z. Malik,et al. 5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced Friend erythroleukemic cells. , 1979, Cell differentiation.
[92] T J Dougherty,et al. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.
[93] S. Granick. HEPATIC PORPHYRIA AND DRUG‐INDUCED OR CHEMICAL PORPHYRIA * , 1965, Annals of the New York Academy of Sciences.
[94] D. Drabkin. INTRODUCTION: SOME HISTORICAL HIGHLIGHTS IN KNOWLEDGE OF PORPHYRINS AND PORPHYRIAS , 1963 .
[95] A. Neuberger,et al. The metabolism of δ-aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N , 1956 .
[96] L. Guillou,et al. Clinical assessment of fluorescence cystoscopy during transurethral bladder resection in superficial bladder cancer , 2004, Urological Research.
[97] Michael Landthaler,et al. Photodynamic therapy and fluorescence diagnosis of skin cancers. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[98] M Korell,et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. , 1999, Obstetrics and gynecology.
[99] W Roessler,et al. 5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors. , 1999, Urology.
[100] R. van Hillegersberg,et al. Kinetics, localization, and mechanism of 5‐aminolevulinic acid‐induced porphyrin accumulation in normal and Barrett's‐like rat esophagus , 1999, Lasers in surgery and medicine.
[101] N. J. Brown,et al. Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. , 1997, British Journal of Cancer.
[102] H. Kerl,et al. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. , 1997, Dermatology.
[103] L. Braathen,et al. Topical photodynamic therapy in verrucae. A pilot study. , 1995, Dermatology.
[104] J. Marriott. Regulation of porphyrin synthesis. , 1968, Biochemical Society Symposium.
[105] W. Star,et al. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. , 1994, British Journal of Cancer.
[106] L. Guillou,et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study , 1999, British Journal of Cancer.